JPWO2020053239A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020053239A5 JPWO2020053239A5 JP2021537505A JP2021537505A JPWO2020053239A5 JP WO2020053239 A5 JPWO2020053239 A5 JP WO2020053239A5 JP 2021537505 A JP2021537505 A JP 2021537505A JP 2021537505 A JP2021537505 A JP 2021537505A JP WO2020053239 A5 JPWO2020053239 A5 JP WO2020053239A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- seq
- fusion protein
- antibody
- mutations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18193663 | 2018-09-11 | ||
| EP18193663.4 | 2018-09-11 | ||
| EP19160485.9 | 2019-03-04 | ||
| EP19160485 | 2019-03-04 | ||
| PCT/EP2019/074153 WO2020053239A1 (en) | 2018-09-11 | 2019-09-11 | Epitope tags recognized by specific binders |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022500076A JP2022500076A (ja) | 2022-01-04 |
| JPWO2020053239A5 true JPWO2020053239A5 (https=) | 2022-09-16 |
| JP2022500076A5 JP2022500076A5 (https=) | 2022-09-16 |
| JP7623006B2 JP7623006B2 (ja) | 2025-01-28 |
Family
ID=68138006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537505A Active JP7623006B2 (ja) | 2018-09-11 | 2019-09-11 | 特異的結合剤により認識されるエピトープタグ |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US12365705B2 (https=) |
| EP (1) | EP3849996B1 (https=) |
| JP (1) | JP7623006B2 (https=) |
| CN (1) | CN113195516B (https=) |
| WO (1) | WO2020053239A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023216437A1 (en) * | 2022-02-02 | 2024-08-15 | BioNTech SE | Agents and methods for targeted delivery of nucleic acids to cells |
| AU2023214781A1 (en) * | 2022-02-02 | 2024-08-15 | BioNTech SE | Cyclic epitope tags |
| EP4472672A1 (en) * | 2022-02-02 | 2024-12-11 | BioNTech SE | Agents and methods for targeted delivery to cells |
| CA3251998A1 (en) | 2022-05-16 | 2023-11-23 | Byondis B.V. | Novel masked antibodies |
| CN117802045A (zh) | 2022-09-30 | 2024-04-02 | 北京恩康医药有限公司 | 一种工程化细胞外囊泡的构建及其应用 |
| US12565665B2 (en) | 2022-12-21 | 2026-03-03 | Trustees Of Boston University | Compositions and methods for controlled mRNA translation and stability |
| WO2024172152A1 (ja) * | 2023-02-17 | 2024-08-22 | 国立大学法人 東京大学 | 細胞外小胞の運命記録システム |
| WO2025021277A1 (en) * | 2023-07-21 | 2025-01-30 | BioNTech SE | Agents and methods for targeted delivery of cytokines to immune cells |
| EP4520768A1 (en) | 2023-09-06 | 2025-03-12 | BioNTech SE | Vhh-ch3 fusion proteins |
| WO2025078418A1 (en) | 2023-10-10 | 2025-04-17 | Nano Tag Biotechnologies Gmbh | Humanized single-domain antibodies binding to epitope tags |
| AR134082A1 (es) | 2023-10-11 | 2025-12-03 | BioNTech SE | Agentes y métodos para la administración dirigida de células efectoras inmunitarias |
| WO2025219955A1 (en) * | 2024-04-17 | 2025-10-23 | BioNTech SE | Soluble tcrs and methods of use thereof |
| CN120923600A (zh) * | 2024-05-09 | 2025-11-11 | 福建医科大学 | 一种超稳定红色荧光蛋白 |
| US20260015401A1 (en) * | 2024-07-10 | 2026-01-15 | Angeles Therapeutics, Inc. | Compositions and methods comprising epitopes and polypeptides |
| WO2026019685A1 (en) * | 2024-07-17 | 2026-01-22 | Harpoon Therapeutics, Inc. | Her2 targeting trispecific protein for treatment of cancer |
| CN118909142A (zh) * | 2024-08-07 | 2024-11-08 | 北京爱思益普生物科技股份有限公司 | Irak4蛋白的制备方法及其所采用的融合蛋白 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU701578B2 (en) * | 1992-08-21 | 1999-02-04 | Vrije Universiteit Brussel | Immunoglobulins devoid of light chains |
| US20040014955A1 (en) | 2001-12-17 | 2004-01-22 | Carlos Zamudio | Identification of essential genes of cryptococcus neoformans and methods of use |
| WO2004041867A2 (en) * | 2002-11-08 | 2004-05-21 | Ablynx N.V. | Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| US20090022720A1 (en) * | 2007-07-20 | 2009-01-22 | Stephan Fischer | Conjugate of an antibody against CD4 and antifusogenic peptides |
| US7678883B2 (en) * | 2007-07-25 | 2010-03-16 | E.I. Du Pont De Nemours And Company | Solubility tags for the expression and purification of bioactive peptides |
| GB201008682D0 (en) | 2010-05-25 | 2010-07-07 | Vib Vzw | Epitope tag for affinity based applications |
| CN107406514B (zh) * | 2014-11-03 | 2021-11-30 | 默克专利有限公司 | 可溶内含肽融合蛋白以及用于纯化生物分子的方法 |
| EP3168306A1 (en) | 2015-11-16 | 2017-05-17 | ChromoTek GmbH | Epitope tag and method for detection and/or purification of tagged polypeptides |
-
2019
- 2019-09-11 CN CN201980074346.7A patent/CN113195516B/zh active Active
- 2019-09-11 JP JP2021537505A patent/JP7623006B2/ja active Active
- 2019-09-11 EP EP19782903.9A patent/EP3849996B1/en active Active
- 2019-09-11 WO PCT/EP2019/074153 patent/WO2020053239A1/en not_active Ceased
- 2019-09-11 US US17/274,755 patent/US12365705B2/en active Active
-
2025
- 2025-06-10 US US19/234,249 patent/US20260103489A1/en active Pending
- 2025-06-10 US US19/234,256 patent/US20260103490A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022500076A5 (https=) | ||
| JPWO2020053239A5 (https=) | ||
| JP7623006B2 (ja) | 特異的結合剤により認識されるエピトープタグ | |
| Kipriyanov et al. | Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment–core streptavidin fusion | |
| JP2020186248A5 (https=) | ||
| Dübel et al. | Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv) | |
| JP2019521643A5 (https=) | ||
| CA2468583C (en) | Self-assembling multimeric binding complexes derived from ab5 toxin family members | |
| JP2019514361A5 (https=) | ||
| US11384141B2 (en) | Serum albumin binding antibodies for tuneable half-life extension of biologics | |
| JP2020530293A5 (https=) | ||
| JP2001521496A (ja) | 高い結合活性の多価および多特異的試薬 | |
| WO2021092075A1 (en) | IL-2RβγC BINDING COMPOUNDS | |
| WO2009142773A4 (en) | Multivalent fibronectin based scaffold domain proteins | |
| JP2019535262A5 (https=) | ||
| JP2017501728A5 (https=) | ||
| RU2016149596A (ru) | Новые полипептиды со специфическим связыванием и пути их применения | |
| CN105658228B (zh) | 结合人类补体c5的稳定多肽 | |
| WO2021207613A1 (en) | Frb antibodies | |
| JP2009525725A (ja) | 血小板抗原特異抗体の結合を中和するペプチドアプタマー並びにそれを含む診断及び治療への応用 | |
| CN118878670A (zh) | 一种抗基孔肯雅热双特异性抗体8d1-7h9及应用 | |
| JPWO2022183074A5 (https=) | ||
| CN115433277A (zh) | 抗cd38兔重组单克隆抗体的制备及应用 | |
| Chen | In vitro production of multimeric and multispecific nanobodies with the peptidisc technology | |
| CN107629112B (zh) | 一种高亲和性lc3蛋白靶向肽及其应用 |